Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Columbia University
Kyowa Kirin Co., Ltd.
National Institutes of Health Clinical Center (CC)
University of Nebraska
National Cancer Institute (NCI)
Stanford University
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Northwestern University
Mayo Clinic
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Mayo Clinic
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
University of Chicago
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
University of Washington
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Stanford University
Fred Hutchinson Cancer Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Barbara Ann Karmanos Cancer Institute
Vanderbilt University
Fred Hutchinson Cancer Center